IceCure’s landmark US clinical trial, ICE3, for nitrogen-based cryoablation of small, low-risk, early stage malignant breast tumors without subsequently removing them, featured in Interventional News.
Cryoablation shows promise in treating low-risk breast cancers. “If the positive preliminary findings are maintained as the patients enrolled in the study continue to be monitored, that will serve as a strong indication of the promise of cryotherapy as an alternative treatment for a specific group of breast cancer patients,” said study lead author Kenneth R Tomkovich, radiologist at Princeton Radiology and director of Breast Imaging and Interventions at CentraState Medical Center in Freehold, USA.
